Further experiments verified that Fatostatin effectively reversed the stimulatory effect of SREBP1 on the proliferative capacity (Supplementary Fig. 4D, E) and the migratory and invasive properties of BC cells (Supplementary Fig. 4F–J). This evidence concerns the gene SREBF1 and breast cancer.